{"database": "lobbying", "table": "lobbying_activities", "rows": [[1457017, "aab03204-0885-49af-9b03-b4b1172b4fac", "Q3", "BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC", 292972, "BOEHRINGER INGELHEIM USA CORPORATION", 2013, "third_quarter", "ANI", "Illegal Compounding", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 490000, 0, 0, "2013-10-21T09:19:17.547000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1457017"], "units": {}, "query_ms": 0.33440091647207737, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}